len pembro metastatic clear cell renal cell carcinoma
Published 4 years ago • 601 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
1:17
treating non-clear cell renal cell carcinoma patients
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
2:22
adjuvant pembrolizumab and survival in renal-cell carcinoma | nejm
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
0:53
what is clear cell renal cell carcinoma?
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
1:02
non-clear cell sarcamatoid kidney cancer treatment updates
-
1:16
the challenges in treating renal cell carcinoma
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
1:32
surgery after immunotherapy for renal cell carcinoma
-
0:53
unanswered questions in the management of clear cell rcc
-
4:44
vegfr inhibitors with immune checkpoint inhibitors for advanced renal cancer
-
2:06
lenvatinib plus pembro for arcc - update on the clear study
-
5:23
immunotherapy-based management of metastatic clear-cell and variant rcc: what can we achieve?
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc